In CKD patients, inflammatory processes and oxidative stress predominate, including increased TNF-α, IL-6, and NF-κB activation, which also alter the immune system and adipose tissue through the production and secretion of adipokines, contributing to a systemic inflammatory state in CKD. Here, NFKB1 is linked to chronic kidney disease.